• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT015
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Codes Bacterial Infection (1735); Conjunctivitis (1784); Endophthalmitis (1835); Inflammation (1932); Fibrosis (3167); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 06/15/2023
Type of Reportable Event Serious Injury
Event or Problem Description
A physician reported that following an intraocular lens (iol) implant procedure, patient started complaining of complication and diagnosed with endophthalmitis.Additional information has been received and provided culture report which stated in grams staining (culture), many pus cells, few gram positive cocci in pairs & clusters were seen.And organism isolated (fluid) was staphylococcus epidermidis.
 
Additional Manufacturer Narrative
The product was not returned for analysis; the lens remains implanted.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
Additional information provided in h.3., and h.10.Information was provided that the fluid culture identified staphylococcus epidermidis, which is part of the normal human microbiota.Previously submitted "fibrosis" fda patient code was sent in error and hence removed.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
Additional information provided in a.1., b.2., b.5., b.7., d.6.A., e.4., h.3.And h.6.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been received and provided the patient had vitreous inflammation, conjunctival inflammation, aqueous cell were seen, aqueous fibrin present.Vitrectomy was performed.It was mentioned that while injecting the lens, a small filmsy membrane was seen at the edge of the lens which was removed with a good viscoelastic at the end.The patient symptoms were improving.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17333698
Report Number1119421-2023-01269
Device Sequence Number17796407
Product Code POE
UDI-Device Identifier00380652421256
UDI-Public00380652421256
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberDFT015
Device Lot Number15372543
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 06/20/2023
Supplement Date Received by Manufacturer07/19/2023
09/05/2023
Initial Report FDA Received Date07/17/2023
Supplement Report FDA Received Date08/11/2023
09/26/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/17/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age59 YR
Patient SexMale
-
-